Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Auxilium Pharmaceuticals to merge with canadian biotechnology company QLT


Thursday, 26 Jun 2014 07:00am EDT 

Auxilium Pharmaceuticals Inc and QLT Inc:Enters into a definitive agreement under which Auxilium plans to merge with QLT.Transaction is expected to drive shareholder value creation by accelerating Auxilium's ongoing transformation into a diversified North American specialty biopharmaceutical company.Under the terms of the agreement, a wholly-owned subsidiary of QLT will be merged with and into Auxilium.QLT will remain incorporated in British Columbia, Canada, and will be renamed "New Auxilium.".Combined organization will be led by Auxilium's current leadership team and will maintain Auxilium's current offices in Chesterbrook, Pennsylvania. 

Company Quote

34.28
 --
26 Nov 2014